Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

185 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03095248	Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors(SEL-TH-1601)	terminated	Phase 2	10	Children's Hospital Medical Center, CincinnatiOTHER	1	Apr 22, 2025	clinicaltrials
NCT03016091	A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma	terminated	Phase 2	18	Rabin Medical CenterOTHER	1	Feb 18, 2025	clinicaltrials